Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.24.0.1
Stockholders’ Equity (Tables)
 6 Months Ended
Jan. 31, 2024
Stockholders’ Equity [Abstract]  
Schedule of Share-based Compensation Expense The amounts of share-based compensation expense recognized in the periods presented are as follows:
    Three months ended
January 31,		     Six months ended
January 31,		  
    2024     2023     2024     2023  
Stock options and performance stock units   $ 98     $ 233     $ 743     $ 412  
Restricted stock units     163       202       593       388  
    $ 261     $ 435     $ 1,336     $ 800  
The following table sets forth the amount of expense related to share-based payment arrangements included in specific line items in the accompanying statements of operations:
    Three months ended
January 31,		     Six months ended
January 31,		  
    2024     2023     2024     2023  
Selling, general and administrative   $ 249     $ 429     $ 1,319     $ 789  
Cost of revenues     12       6       17       11  
    $ 261     $ 435     $ 1,336     $ 800  
Schedule of Stock Option Activity The following table summarizes stock option activity during the six month period ended January 31, 2024:
    Options     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term		   Aggregate
Intrinsic
Value
(000s)		  
Outstanding at July 31, 2023     3,829,500     $ 2.61          
—
  
Granted    
—
      
—
              
Exercised    
—
      
—
         $    
Cancelled or expired     (1,355,130 )   $ 1.72              
Outstanding at end of period     2,474,370     $ 2.69     2.6 years   $
—
  
Exercisable at end of period     2,313,784     $ 2.83     1.7 years   $
—
  
Schedule of Restricted Stock Unit (“RSU”) Activity The following table summarizes RSU activity for the six months ended January 31, 2024:
    Number of
RSUs
outstanding		     Weighted
Average Fair
Value per
Unit at
Date of
Grant		     Weighted
Average
Remaining
Contractual
Term		   Aggregate
Intrinsic
Value (000s)		  
Outstanding at beginning of fiscal year     557,490     $ 2.21     1.1 years     825  
Granted     255,825     $ 1.27          
—
  
Vested     (191,063 )   $ 3.21              
Cancelled     (100,000 )   $ 1.97              
Outstanding at end of period     522,252     $ 1.44     0.5 years   $ 658  
Expected to vest at end of period     522,252     $ 1.44     0.5 years   $ 658